Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-25-016818
Filing Date
2025-04-04
Accepted
2025-04-04 16:48:56
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 resales-3march2024financing.htm S-3 245421
2 EX-FILING FEES exhibit107-resalesx3.htm EX-FILING FEES 14054
3 EX-5.1 exhibit51-resalesx3.htm EX-5.1 15590
4 EX-23.1 exhibit231-resalesx3.htm EX-23.1 2084
5 a1.jpg GRAPHIC 375723
6 prospectuscover.jpg GRAPHIC 132972
7 wilsonlogoa.jpg GRAPHIC 12960
  Complete submission text file 0001628280-25-016818.txt   960878
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286397 | Film No.: 25815529
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)